top of page
![News Headings.jpg](https://static.wixstatic.com/media/22ea40_5124864fef57437b8c782287bc11c9c1~mv2.jpg/v1/fill/w_980,h_396,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/22ea40_5124864fef57437b8c782287bc11c9c1~mv2.jpg)
NEWS & BLOGS
Blog: Blog2
![](https://static.wixstatic.com/media/22ea40_bf30400ae0df4b9faa12ed9d87c346e5~mv2.jpg/v1/fill/w_250,h_250,fp_0.50_0.50,q_30,blur_30,enc_auto/22ea40_bf30400ae0df4b9faa12ed9d87c346e5~mv2.webp)
![FDA, guidance of Pre-Submission](https://static.wixstatic.com/media/22ea40_bf30400ae0df4b9faa12ed9d87c346e5~mv2.jpg/v1/fill/w_454,h_256,fp_0.50_0.50,q_90,enc_auto/22ea40_bf30400ae0df4b9faa12ed9d87c346e5~mv2.webp)
Provision Consulting Group
Mar 14, 20222 min read
FDA, guidance of Pre-Submission
We want to give you some advice on Pre-Submission which leads to successful FDA approval. FDA offers a Pre-submission program and...
68
![](https://static.wixstatic.com/media/22ea40_7b70e7f8c33b4a9082a5d20f83bdfb96~mv2.jpg/v1/fill/w_250,h_250,fp_0.50_0.50,q_30,blur_30,enc_auto/22ea40_7b70e7f8c33b4a9082a5d20f83bdfb96~mv2.webp)
![FDA Clinical Trial Guidances for Advancing Development of Cancer Treatments](https://static.wixstatic.com/media/22ea40_7b70e7f8c33b4a9082a5d20f83bdfb96~mv2.jpg/v1/fill/w_454,h_256,fp_0.50_0.50,q_90,enc_auto/22ea40_7b70e7f8c33b4a9082a5d20f83bdfb96~mv2.webp)
Provision Consulting Group
Mar 8, 20223 min read
FDA Clinical Trial Guidances for Advancing Development of Cancer Treatments
Mar 08 2022 March 01 2022, the U.S. Food and Drug Administration issued three final guidances to industry regarding cancer clinical...
28
![FDA, CDER's Drug Approvals and Programming to Speed Therapeutic Development](https://static.wixstatic.com/media/22ea40_66edb507bf384c3a98a25fb15c5b9dc6~mv2.png/v1/fill/w_454,h_256,fp_0.50_0.50,q_95,enc_auto/22ea40_66edb507bf384c3a98a25fb15c5b9dc6~mv2.webp)
Provision Consulting Group
Mar 7, 20223 min read
FDA, CDER's Drug Approvals and Programming to Speed Therapeutic Development
Mar 07 2022 FDA I Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research A rare disease is any disease that...
25
![OTC Monograph Reform: Overview of Draft Guidance for Formal Meetings](https://static.wixstatic.com/media/22ea40_0c06be7b8683416099d0eb031aa53d8b~mv2.png/v1/fill/w_454,h_256,fp_0.50_0.50,q_95,enc_auto/22ea40_0c06be7b8683416099d0eb031aa53d8b~mv2.webp)
Provision Consulting Group
Mar 7, 20221 min read
OTC Monograph Reform: Overview of Draft Guidance for Formal Meetings
Mar 07 2022 Date: March 29, 2022 Time: 2:00 PM - 3:00 PM ET ABOUT THIS WEBINAR During this webinar, FDA will provide an overview of the...
25
![](https://static.wixstatic.com/media/22ea40_d8f4ae08cc474f7fa58572901942e643~mv2.jpg/v1/fill/w_250,h_250,fp_0.50_0.50,q_30,blur_30,enc_auto/22ea40_d8f4ae08cc474f7fa58572901942e643~mv2.webp)
![FDA Regulation, Soaps & Lotions](https://static.wixstatic.com/media/22ea40_d8f4ae08cc474f7fa58572901942e643~mv2.jpg/v1/fill/w_454,h_256,fp_0.50_0.50,q_90,enc_auto/22ea40_d8f4ae08cc474f7fa58572901942e643~mv2.webp)
Provision Consulting Group
Mar 3, 20224 min read
FDA Regulation, Soaps & Lotions
Mar 03 2022 We provide safety and regulatory information about soaps and lotions. Lotions, soaps, and other cleansers may be regulated as...
65
![](https://static.wixstatic.com/media/22ea40_bd4b1e39b65f45c3bfa39849c6866ba2~mv2.jpg/v1/fill/w_250,h_250,fp_0.50_0.50,q_30,blur_30,enc_auto/22ea40_bd4b1e39b65f45c3bfa39849c6866ba2~mv2.webp)
![FDA Regulation, Cosmetics or Drugs?](https://static.wixstatic.com/media/22ea40_bd4b1e39b65f45c3bfa39849c6866ba2~mv2.jpg/v1/fill/w_454,h_256,fp_0.50_0.50,q_90,enc_auto/22ea40_bd4b1e39b65f45c3bfa39849c6866ba2~mv2.webp)
Provision Consulting Group
Mar 2, 20223 min read
FDA Regulation, Cosmetics or Drugs?
Mar 02 2022 The Food and Drug Administration (FDA) warns cosmetics companies when they make claims about their products that classify...
45
![](https://static.wixstatic.com/media/22ea40_cf7ab3fa1adc4f638fadc7f20ae3a953~mv2.jpg/v1/fill/w_250,h_250,fp_0.50_0.50,q_30,blur_30,enc_auto/22ea40_cf7ab3fa1adc4f638fadc7f20ae3a953~mv2.webp)
![FDA approves drug for adults with rare form of bone marrow disorder](https://static.wixstatic.com/media/22ea40_cf7ab3fa1adc4f638fadc7f20ae3a953~mv2.jpg/v1/fill/w_454,h_256,fp_0.50_0.50,q_90,enc_auto/22ea40_cf7ab3fa1adc4f638fadc7f20ae3a953~mv2.webp)
Provision Consulting Group
Mar 1, 20222 min read
FDA approves drug for adults with rare form of bone marrow disorder
Mar 01 2022 FDA has granted accelerated approval for Vonjo (pacritinib) capsules to treat adults who have a rare form of a bone marrow...
24
![](https://static.wixstatic.com/media/22ea40_61a37fcbc2064602ab85f7726496490e~mv2.jpg/v1/fill/w_250,h_250,fp_0.50_0.50,q_30,blur_30,enc_auto/22ea40_61a37fcbc2064602ab85f7726496490e~mv2.webp)
![FDA updates Sotrovimab emergency use authorization](https://static.wixstatic.com/media/22ea40_61a37fcbc2064602ab85f7726496490e~mv2.jpg/v1/fill/w_454,h_256,fp_0.50_0.50,q_90,enc_auto/22ea40_61a37fcbc2064602ab85f7726496490e~mv2.webp)
Provision Consulting Group
Feb 28, 20221 min read
FDA updates Sotrovimab emergency use authorization
Feb 28 2022 [2/25/2022] The U.S. Food and Drug Administration is continually monitoring how authorized and approved treatments for...
21
![](https://static.wixstatic.com/media/22ea40_7b1173ae9b7b42cda2cb2bfd183363ee~mv2.jpg/v1/fill/w_250,h_250,fp_0.50_0.50,q_30,blur_30,enc_auto/22ea40_7b1173ae9b7b42cda2cb2bfd183363ee~mv2.webp)
![FDA authorizes revisions to Evusheld dosing](https://static.wixstatic.com/media/22ea40_7b1173ae9b7b42cda2cb2bfd183363ee~mv2.jpg/v1/fill/w_454,h_256,fp_0.50_0.50,q_90,enc_auto/22ea40_7b1173ae9b7b42cda2cb2bfd183363ee~mv2.webp)
Provision Consulting Group
Feb 28, 20223 min read
FDA authorizes revisions to Evusheld dosing
Feb 28 2022 [2/24/2022] The U.S. Food and Drug Administration has revised the emergency use authorization for Evusheld (tixagevimab...
31
![](https://static.wixstatic.com/media/22ea40_1667372c4c3742eab9edad15b6ad57fd~mv2.jpg/v1/fill/w_250,h_250,fp_0.50_0.50,q_30,blur_30,enc_auto/22ea40_1667372c4c3742eab9edad15b6ad57fd~mv2.webp)
![FDA Approves Treatment for Wider Range of Patients with Heart Failure](https://static.wixstatic.com/media/22ea40_1667372c4c3742eab9edad15b6ad57fd~mv2.jpg/v1/fill/w_454,h_256,fp_0.50_0.50,q_90,enc_auto/22ea40_1667372c4c3742eab9edad15b6ad57fd~mv2.webp)
Provision Consulting Group
Feb 24, 20222 min read
FDA Approves Treatment for Wider Range of Patients with Heart Failure
Feb 24 2022 Today, the U.S. Food and Drug Administration approved Jardiance (empagliflozin) to reduce the risk of cardiovascular death...
21
bottom of page